4.5 Article

Benzoxacystol, a benzoxazine-type enzyme inhibitor from the deep-sea strain Streptomyces sp NTK 935

Journal

JOURNAL OF ANTIBIOTICS
Volume 64, Issue 6, Pages 453-457

Publisher

JAPAN ANTIBIOTICS RESEARCH ASSOC
DOI: 10.1038/ja.2011.26

Keywords

1,4-benzoxazin-3-one; glycogen synthase kinase 3 beta; marine Streptomyces

Funding

  1. Boehringer-Ingelheim Pharma GmbH (Biberach, Germany)
  2. European Commission [LSHM-CT-2004-005224]

Ask authors/readers for more resources

Benzoxacystol, a new 1,4-benzoxazine-type metabolite, was produced by strain NTK 935, a marine member of the Streptomyces griseus 16S rRNA clade, isolated from deep-sea sediment collected from the Canary Basin. The structure of benzoxacystol was determined by mass spectrometry, NMR experiments and X-ray analysis. The compound showed an inhibitory activity against the enzyme glycogen synthase kinase 3 beta and a weak antiproliferative activity against mouse fibroblast cells. The Journal of Antibiotics (2011) 64, 453-457; doi:10.1038/ja.2011.26; published online 20 April 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available